Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Celastrol at 2
Cidofovir is an acyclic nucleoside phosphonate
InChi: InChI=1S/C25H23F3N4O2/c26-25(27
Alda-1 administration leads to 2 and 10 differentially expressed proteins in the FCx and Hp of apoE−/− mice
Smiles: CC1C=CC(=CC=1)C1C2=C(N)N=CN=C2N(CCCO)C=1C(=O)CF
Laquinimod Catalog No.:M11360-2 Celastrol at 2Laquinimod, also known as, is an experimental immunomodulator developed by Active Biotech and Teva. It is being investigated as an oral treatment for multiple sclerosis (MS). Laquinimod is the successor of Active Biotech's failed experimental immunomodulator linomide. Laquinimod seems to be able to reduce the MS disease activity on MRI. In 2011, Teva announced its clinical trials involving laquinimod had failed, being unable to significantly reduce
US$ 45.00
US$ 40.00
US$ 40.00
US$ 40.00
US$ 128.88
US$ 155.00
US$ 45.00
US$ 40.00